Search Results

Mechanisms of Drug Induced QT Interval Prolongation

Authors: Ponte, Marcelo L.; Keller, Guillermo A.l.b.e.r.t.o.; Girolamo, Guillermo D.i.

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 44-53(10)

Publisher: Bentham Science Publishers

Semi-Mechanistic Population Pharmacokinetic Drug-Drug Interaction Modelling of a Long Half-Life Substrate and Itraconazole

Authors: Lehr, Thorsten; Staab, Alexander; Trommeshauser, Dirk; >Hans Guenter Schaefer,; Kloft, Charlotte

Source: Clinical Pharmacokinetics, Volume 49, Number 1, 1 January 2010 , pp. 53-66(14)

Publisher: Adis International

Interaction Between Clopidogrel and Proton Pump Inhibitors: Hypothesis to Explain Multifactorial CYP2C19 Inhibition

Authors: Zhang, Huixia; Ragueneau-Majlessi, Isabelle; Levy, Rene H.

Source: Drug Metabolism Letters, Volume 3, Number 4, December 2009 , pp. 287-289(3)

Publisher: Bentham Science Publishers

Pantoprazole: A Proton Pump Inhibitor

Author: >Luis Moreira Dias,

Source: Clinical Drug Investigation, Volume 29, Supplement 2, 24 November 2009 , pp. 3-12(10)

Publisher: Adis International

Laboratory Tests in the Clinical Risk Management of Potential Drug-Drug Interactions: A Cross-Sectional Study Using Drug-Dispensing Data from 100 Dutch Community Pharmacies

Authors: Geerts, Arjen F.J.; De Koning, Fred H.P.; De Smet, Peter A.G.M.; Van Solinge, Wouter W.; Egberts, Toine C.G.

Source: Drug Safety, Volume 32, Number 12, 1 December 2009 , pp. 1189-1197(9)

Publisher: Adis International

Roles of Different CYP Enzymes in the Formation of Specific Fluvastatin Metabolites by Human Liver Microsomes

Authors: Toda, Takaki; Eliasson, Erik; Ask, Birgitta; Inotsume, Nobuo; Rane, Anders

Source: Basic & Clinical Pharmacology & Toxicology, Volume 105, Number 5, November 2009 , pp. 327-332(6)

Publisher: Blackwell Publishing

Is There a Place for Drug Combination Strategies Using Clinical Pharmacology Attributes? - Review of Current Trends in Research

Author: Srinivas, Nuggehally R.

Source: Current Clinical Pharmacology, Volume 4, Number 3, September 2009 , pp. 220-228(9)

Publisher: Bentham Science Publishers

Spin-Lattice Relaxation Time in Drug Discovery and Design

Authors: Figueroa-Villar, Jose D.; Tinoco, Luzineide W.a.n.d.e.r.l.e.y.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 9, June 2009 , pp. 811-823(13)

Publisher: Bentham Science Publishers

A Proposal for a Pharmacokinetic Interaction Significance Classification System (PISCS) Based on Predicted Drug Exposure Changes and Its Potential Application to Alert Classifications in Product Labelling

Authors: Hisaka, Akihiro; Kusama, Makiko; Ohno, Yoshiyuki; Sugiyama, Yuichi; Suzuki, Hiroshi

Source: Clinical Pharmacokinetics, Volume 48, Number 10, 1 October 2009 , pp. 653-666(14)

Publisher: Adis International

Drug-Drug Interaction Prediction Assessment

Authors: Zhou, Jihao; Qin, Zhaohui; Sara, Quinney; Kim, Seongho; Wang, Zhiping; Hall, Stephen; Li, Lang

Source: Journal of Biopharmaceutical Statistics, Volume 19, Number 4, July 2009 , pp. 641-657(17)

Publisher: Taylor and Francis Ltd

Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

Authors: Mori, K.; Hashimoto, H.; Takatsu, H.; Tsuda-Tsukimoto, M.; Kume, T.

Source: Xenobiotica, Volume 39, Number 6, June 2009 , pp. 415-422(8)

Publisher: Informa Healthcare

Drug interactions

Authors: Boobis, Alan; Watelet, Jean-Baptiste; Whomsley, Rhys; Benedetti, Margherita Strolin; Demoly, Pascal; Tipton, Keith

Source: Drug Metabolism Reviews, Volume 41, Number 3, August 2009 , pp. 486-527(42)

Publisher: Informa Healthcare

Management of Metabolic Cytochrome P450 3A4 Drug-Drug Interaction between Everolimus and Azole Antifungals in a Renal Transplant Patient

Authors: Billaud, E.M.; Antoine, C.; Berge, M.; Abboud, I.; Lefeuvre, S.; Benammar, M.; Glotz, D.

Source: Clinical Drug Investigation, Volume 29, Number 7, 5 June 2009 , pp. 481-486(6)

Publisher: Adis International

Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes*

Authors: He, Yan-Ling; Sabo, Ron; Picard, Franck; Wang, Yibin; Herron, Jerry; Ligueros-Saylan, Monica; Dole, William P.

Source: Current Medical Research and Opinion, Volume 25, Number 5, May 2009 , pp. 1265-1272(8)

Publisher: Informa Healthcare

Prevalence of Polypharmacy, Polyherbacy, Nutritional Supplement Use and Potential Product Interactions among Older Adults Living on the United States-Mexico Border: A Descriptive, Questionnaire-Based Study

Authors: Loya, Amanda M.; González-Stuart, Armando; Rivera, José O.

Source: Drugs & Aging, Volume 26, Number 5, May 5 2009 , pp. 423-436(14)

Publisher: Adis International

Metabolic interactions with piperazine-based `party pill' drugs

Authors: Antia, Ushtana; Tingle, Malcolm D.; Russell, Bruce R.

Source: Journal of Pharmacy and Pharmacology, Volume 61, Number 7, July 2009 , pp. 877-882(6)

Publisher: Pharmaceutical Press

Fatal drug-drug interaction of brivudine and capecitabine

Authors: Ratz Bravo, Alexandra; Hofer, Silvia; Krahenbuhl, Stephan; Ludwig, Christian

Source: Acta Oncologica, Volume 48, Number 4, May 2009 , pp. 631-633(3)

Publisher: Informa Healthcare

Augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Rican and Mexican children

Authors: Tcheurekdjian, Haig; Thyne, Shannon M.; Williams, L K.; Via, Marc; Rodriguez-Santana, Jose R.; Rodriguez-Cintron, William; Avila, Pedro C.; Burchard, Esteban G.o.n.z..l.e.z.

Source: Annals of Allergy, Asthma and Immunology, Volume 102, Number 6, June 2009 , pp. 510-517(8)

Publisher: American College of Allergy, Asthma, & Immunology

Caffeine Metabolic Ratios for the In Vivo Evaluation of CYP1A2, N-acetyltransferase 2, Xanthine Oxidase and CYP2A6 Enzymatic Activities

Author: Hakooz, Nancy M.K.h.

Source: Current Drug Metabolism, Volume 10, Number 4, May 2009 , pp. 329-338(10)

Publisher: Bentham Science Publishers

Development of Decision Tree Models for Substrates, Inhibitors, and Inducers of P-Glycoprotein

Authors: Hammann, Felix; Gutmann, Heike; Jecklin, Ursula; Maunz, Andreas; Helma, Christoph; Drewe, Juergen

Source: Current Drug Metabolism, Volume 10, Number 4, May 2009 , pp. 339-346(8)

Publisher: Bentham Science Publishers